FEB 11, 2020 11:27 AM PST

Could we be over-diagnosing cancer?

Roughly one in every two people are estimated to receive a cancer diagnosis at some point in their lives, but are all of those diagnoses valid? New research from the Medical Journal of Australia suggests that we are over-diagnosing cancer.

But what does over-diagnosis mean? It doesn’t mean that the doctors are saying people have cancer when they don’t; instead, it refers to how doctors treat cancers that do not necessarily cause harm with severe cancer drugs, which often negatively affect the person’s quality of life.

Led by Professor Paul Glasziou — the director of the Institute for Evidence-Based Healthcare at Bond University in Queensland, Australia, the research compared current and past lifetime risks of cancer in order to estimate the proportion of cancer diagnoses in Australia that could be attributed to overdiagnosis. The study conducted a comprehensive analysis of national data collected by the Australian Institute of Health and Welfare to compare recent (2012) and historical (1982) lifetime risks of cancer diagnoses for five cancers: prostate, breast, renal, thyroid cancers, and melanoma.

According to the study’s findings, doctors may over-diagnose approximately 11,000 cancers in women and 18,000 cancers in men every year. As the study reports, women saw an “absolute lifetime risk increase of 3.4 percentage points for breast cancer (invasive cancers, 1.7 percentage points), 0.6 percentage point for renal cancer, 1.0 percentage point for thyroid cancer, and 5.1 percentage points for melanoma (invasive melanoma, 0.7 percentage point). An estimated 22% of breast cancers (invasive cancers, 13%), 58% of renal cancers, 73% of thyroid cancers, and 54% of melanomas (invasive melanoma, 15%) were overdiagnosed, or 18% of all cancer diagnoses (8% of invasive cancer diagnoses). For men, absolute lifetime risk increased by 8.2 percentage points for prostate cancer, 0.8 percentage point for renal cancer, 0.4 percentage point for thyroid cancer, and 8.0 percentage points for melanoma (invasive melanoma, 1.5 percentage points). An estimated 42% of prostate cancers, 42% of renal cancers, 73% of thyroid cancers, and 58% of melanomas (invasive melanomas, 22%) were overdiagnosed, or 24% of all cancer diagnoses (16% of invasive cancer diagnoses).”

These over-diagnoses have significant, tangible consequences, particularly financially and mental health. The researchers say that most over-diagnoses occur during routine screening procedures. These procedures, despite aiding in increases overdiagnosis rates, have greatly lowered mortality rates for cancer overall, so the researchers say that despite their findings, more evidence is necessary before health policies should change to reflect their conclusions.

Sources: Medical News Today, Medical Journal of Australia

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
APR 08, 2021
Cancer
What can modifiying cultured cells to act more like normal cells teach us about cancer?
APR 08, 2021
What can modifiying cultured cells to act more like normal cells teach us about cancer?
A team from the University of Louisville has developed a technique to make cell cultures act more like normal cells. Thi ...
MAY 07, 2021
Cancer
Pandemic times haven't been fun for anyone, but they've been especially hard for cancer patients
MAY 07, 2021
Pandemic times haven't been fun for anyone, but they've been especially hard for cancer patients
The pandemic hit everyone hard on many levels; now, new research from UCSF published in Cancer reports that cancer patie ...
MAY 15, 2021
Cancer
What does your polygenic risk score mean?
MAY 15, 2021
What does your polygenic risk score mean?
A study published in The American Journal of Clinical Nutrition recommends that people with a high polygenic risk score ...
MAY 21, 2021
Cancer
How to address low representation of Black Americans in cancer trials
MAY 21, 2021
How to address low representation of Black Americans in cancer trials
The Abramson Cancer Center at the University of Pennsylvania (ACC) has succeeded in more than doubling the enrollment of ...
JUN 04, 2021
Cancer
Cancer patients with COVID-19 fare better with remote health monitoring
JUN 04, 2021
Cancer patients with COVID-19 fare better with remote health monitoring
A new study presented last week at the American Society of Clinical Oncology Annual Meeting after its publication in the ...
JUN 09, 2021
Technology
Computer Program Generates Effective, Clinically-valid Treatment Plans for Cancer Patients
JUN 09, 2021
Computer Program Generates Effective, Clinically-valid Treatment Plans for Cancer Patients
In a recent study published in Nature Medicine, researchers at the Princess Margaret Cancer Centre offer evidence for th ...
Loading Comments...